More Good Technical News for Biotech ETFs

Investors in healthcare stocks and exchange traded funds have likely had their fill of hearing about the sector’s first-quarter doldrums, most of which were caused by a continuing biotechnology slump. Those investors should take heart because bullish technical chatter regarding some marquee...